Thousands of Xarelto lawsuits have been filed against the manufacturer, who allegedly improperly marketed the drug as superior to Warfarin, therefore causing more injuries of irreversible bleeding.
Warfarin, also known as Coumadin, has a bleeding side effect that is reversible with vitamin K. Initially approved in October 2011, Xarelto is used to reduce the risk of deep vein thrombosis and pulmonary embolism, as well as preventing stroke in patients with non-valvular atrial fibrillation.Īn older blood thinner, Warfarin, may also cause major bleeding. The new-age blood thinner is classified as a Factor Xa inhibitor, and like Eliquis, there is no antidote to stop Xarelto bleeding. Johnson & Johnson is the parent company of Janssen, who markets Xarelto alongside Bayer. Some blood thinners come with a higher risk, whereas others have an approved antidote. Xarelto Bleeding Side EffectĪnticoagulants may cause internal bleeding, gastrointestinal bleeding, cranial bleeding, vaginal bleeding, and hemorrhaging.
But that does not mean the FDA should rush the process. The Food and Drug Administration (FDA) has initiated a 90-day extension until May 2018, citing the need for more data.įor tens of thousands of patients who have required hospitalization due to Xarelto bleeding, an antidote is greatly needed. As part of a continued review process, the AndexXa antidote developed to cease potentially-fatal Xarelto bleeding side effects remains unapproved.
0 kommentar(er)
